Topiroxostat is an active pharmaceutical ingredient that functions as a xanthine oxidase inhibitor, used in the manufacturing of medications for conditions related to elevated uric acid levels. It was approved for pharmaceutical use in Japan in 2013.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 577778-58-6
Tigulixostat
pharmaceutical raw material
Oxypurinol
pharmaceutical raw material
Montelukast Dicyclohexylamine Salt
pharmaceutical raw material
Closantel
pharmaceutical raw material
Domperidone
pharmaceutical raw material
Idarubicin hydrochloride
pharmaceutical raw material
4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile
UBVZQGOVTLIHLH-UHFFFAOYSA-N
C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N